Consultation outcome

UK SMI V 58: SARS-CoV-2 serology

This consultation has concluded

Download the full outcome

Detail of outcome

The last full scientific review of this document was completed on 9 June 2022.

Read the latest issue of UK SMI V 58.

Detail of feedback received

Timeline of review process

Date document started: 30 June 2021

First consultation: 22 September 2021 to 6 October 2021

Second consultation: 17 December 2021 to 7 January 2022

Date document issued: 9 June 2022


Original consultation

Summary

This consultation asks for feedback on UK SMI V 58: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) serology.

This consultation ran from
to

Consultation description

UK Health Security Agency (UKHSA) has opened a consultation in joint partnership with professional organisations.

This consultation asks for feedback on UK Standards for Microbiology Investigations (UK SMI) V 58: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) serology.

We have refined the process so that UK SMI users can comment more easily if they see no requirement for amendments to the document out for consultation.

We request that all feedback be provided through the survey form. Do not submit your feedback as a PDF. Enquiries may be directed to the Standards Unit standards@phe.gov.uk.

Documents

UK SMI V 58: closed consultation draft

Published 17 December 2021
Last updated 17 June 2022 + show all updates
  1. Added Review of users' comments: June 2022.

  2. First published.